nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritonavir—Abnormal faeces—Varenicline—nicotine dependence	0.0281	0.0369	CcSEcCtD
Ritonavir—Peripheral vascular disorder—Varenicline—nicotine dependence	0.0164	0.0215	CcSEcCtD
Ritonavir—Myositis—Varenicline—nicotine dependence	0.0164	0.0215	CcSEcCtD
Ritonavir—Throat irritation—Varenicline—nicotine dependence	0.0159	0.0209	CcSEcCtD
Ritonavir—Psoriasis—Varenicline—nicotine dependence	0.0128	0.0168	CcSEcCtD
Ritonavir—Parosmia—Varenicline—nicotine dependence	0.0124	0.0162	CcSEcCtD
Ritonavir—Thrombosis—Varenicline—nicotine dependence	0.0114	0.0149	CcSEcCtD
Ritonavir—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0112	0.0474	CbGpPWpGaD
Ritonavir—Hyperlipidaemia—Varenicline—nicotine dependence	0.0112	0.0146	CcSEcCtD
Ritonavir—Mania—Varenicline—nicotine dependence	0.0111	0.0145	CcSEcCtD
Ritonavir—CYP2E1—CYP2E1 reactions—CYP2A7—nicotine dependence	0.011	0.0464	CbGpPWpGaD
Ritonavir—Menorrhagia—Varenicline—nicotine dependence	0.0109	0.0142	CcSEcCtD
Ritonavir—Scotoma—Varenicline—nicotine dependence	0.0106	0.0139	CcSEcCtD
Ritonavir—Gingivitis—Varenicline—nicotine dependence	0.0102	0.0134	CcSEcCtD
Ritonavir—Nephrolithiasis—Varenicline—nicotine dependence	0.01	0.0131	CcSEcCtD
Ritonavir—Glycosuria—Varenicline—nicotine dependence	0.00993	0.013	CcSEcCtD
Ritonavir—Endocrine disorder—Varenicline—nicotine dependence	0.0097	0.0127	CcSEcCtD
Ritonavir—Acne—Varenicline—nicotine dependence	0.00956	0.0125	CcSEcCtD
Ritonavir—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0095	0.0401	CbGpPWpGaD
Ritonavir—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.00941	0.0397	CbGpPWpGaD
Ritonavir—Disturbance in attention—Varenicline—nicotine dependence	0.00928	0.0122	CcSEcCtD
Ritonavir—Accidental injury—Varenicline—nicotine dependence	0.00909	0.0119	CcSEcCtD
Ritonavir—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.0089	0.0117	CcSEcCtD
Ritonavir—Thinking abnormal—Varenicline—nicotine dependence	0.00878	0.0115	CcSEcCtD
Ritonavir—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00876	0.037	CbGpPWpGaD
Ritonavir—Nocturia—Varenicline—nicotine dependence	0.00867	0.0114	CcSEcCtD
Ritonavir—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00848	0.0358	CbGpPWpGaD
Ritonavir—Coordination abnormal—Varenicline—nicotine dependence	0.00819	0.0107	CcSEcCtD
Ritonavir—Abnormal dreams—Varenicline—nicotine dependence	0.00795	0.0104	CcSEcCtD
Ritonavir—Eructation—Varenicline—nicotine dependence	0.0079	0.0104	CcSEcCtD
Ritonavir—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0078	0.0329	CbGpPWpGaD
Ritonavir—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00774	0.0326	CbGpPWpGaD
Ritonavir—Photophobia—Varenicline—nicotine dependence	0.00755	0.00989	CcSEcCtD
Ritonavir—Oesophagitis—Varenicline—nicotine dependence	0.00735	0.00963	CcSEcCtD
Ritonavir—Mouth ulceration—Varenicline—nicotine dependence	0.00727	0.00953	CcSEcCtD
Ritonavir—Urine output increased—Varenicline—nicotine dependence	0.00727	0.00953	CcSEcCtD
Ritonavir—Mental disability—Varenicline—nicotine dependence	0.00698	0.00915	CcSEcCtD
Ritonavir—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00696	0.0294	CbGpPWpGaD
Ritonavir—Euphoric mood—Varenicline—nicotine dependence	0.00691	0.00905	CcSEcCtD
Ritonavir—Lymphadenopathy—Varenicline—nicotine dependence	0.00684	0.00897	CcSEcCtD
Ritonavir—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.00682	0.0288	CbGpPWpGaD
Ritonavir—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0068	0.0287	CbGpPWpGaD
Ritonavir—Sleep disorder—Varenicline—nicotine dependence	0.00674	0.00884	CcSEcCtD
Ritonavir—Diabetes mellitus—Varenicline—nicotine dependence	0.00671	0.0088	CcSEcCtD
Ritonavir—Polyuria—Varenicline—nicotine dependence	0.00665	0.00871	CcSEcCtD
Ritonavir—Deafness—Varenicline—nicotine dependence	0.00653	0.00855	CcSEcCtD
Ritonavir—Eczema—Varenicline—nicotine dependence	0.0065	0.00851	CcSEcCtD
Ritonavir—Eye pain—Varenicline—nicotine dependence	0.00647	0.00847	CcSEcCtD
Ritonavir—Injury—Varenicline—nicotine dependence	0.00635	0.00832	CcSEcCtD
Ritonavir—Renal failure acute—Varenicline—nicotine dependence	0.00632	0.00829	CcSEcCtD
Ritonavir—Libido decreased—Varenicline—nicotine dependence	0.00629	0.00825	CcSEcCtD
Ritonavir—Amnesia—Varenicline—nicotine dependence	0.00621	0.00814	CcSEcCtD
Ritonavir—Thirst—Varenicline—nicotine dependence	0.00613	0.00804	CcSEcCtD
Ritonavir—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00609	0.0257	CbGpPWpGaD
Ritonavir—Arthritis—Varenicline—nicotine dependence	0.00601	0.00787	CcSEcCtD
Ritonavir—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00589	0.0249	CbGpPWpGaD
Ritonavir—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00584	0.00765	CcSEcCtD
Ritonavir—Osteoarthritis—Varenicline—nicotine dependence	0.00584	0.00765	CcSEcCtD
Ritonavir—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00579	0.00759	CcSEcCtD
Ritonavir—Affect lability—Varenicline—nicotine dependence	0.00575	0.00753	CcSEcCtD
Ritonavir—Migraine—Varenicline—nicotine dependence	0.00575	0.00753	CcSEcCtD
Ritonavir—Urinary retention—Varenicline—nicotine dependence	0.00555	0.00727	CcSEcCtD
Ritonavir—Mood swings—Varenicline—nicotine dependence	0.00553	0.00725	CcSEcCtD
Ritonavir—Liver function test abnormal—Varenicline—nicotine dependence	0.00539	0.00706	CcSEcCtD
Ritonavir—Dry skin—Varenicline—nicotine dependence	0.00535	0.00701	CcSEcCtD
Ritonavir—Breast disorder—Varenicline—nicotine dependence	0.00527	0.00691	CcSEcCtD
Ritonavir—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00526	0.0222	CbGpPWpGaD
Ritonavir—Cramp muscle—Varenicline—nicotine dependence	0.00526	0.00689	CcSEcCtD
Ritonavir—Gastritis—Varenicline—nicotine dependence	0.00517	0.00677	CcSEcCtD
Ritonavir—Abdominal distension—Varenicline—nicotine dependence	0.00508	0.00666	CcSEcCtD
Ritonavir—Dysphagia—Varenicline—nicotine dependence	0.00504	0.00661	CcSEcCtD
Ritonavir—Asthma—Varenicline—nicotine dependence	0.00504	0.00661	CcSEcCtD
Ritonavir—Bronchitis—Varenicline—nicotine dependence	0.00485	0.00636	CcSEcCtD
Ritonavir—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00484	0.0204	CbGpPWpGaD
Ritonavir—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00479	0.0202	CbGpPWpGaD
Ritonavir—Pollakiuria—Varenicline—nicotine dependence	0.00466	0.00611	CcSEcCtD
Ritonavir—Erectile dysfunction—Varenicline—nicotine dependence	0.00465	0.00609	CcSEcCtD
Ritonavir—Photosensitivity reaction—Varenicline—nicotine dependence	0.0046	0.00604	CcSEcCtD
Ritonavir—Hyperglycaemia—Varenicline—nicotine dependence	0.00455	0.00596	CcSEcCtD
Ritonavir—Depression—Varenicline—nicotine dependence	0.00449	0.00588	CcSEcCtD
Ritonavir—Acute coronary syndrome—Varenicline—nicotine dependence	0.00443	0.00581	CcSEcCtD
Ritonavir—Myocardial infarction—Varenicline—nicotine dependence	0.00441	0.00578	CcSEcCtD
Ritonavir—Stomatitis—Varenicline—nicotine dependence	0.00438	0.00575	CcSEcCtD
Ritonavir—Conjunctivitis—Varenicline—nicotine dependence	0.00437	0.00573	CcSEcCtD
Ritonavir—Hepatobiliary disease—Varenicline—nicotine dependence	0.00425	0.00558	CcSEcCtD
Ritonavir—Epistaxis—Varenicline—nicotine dependence	0.00424	0.00556	CcSEcCtD
Ritonavir—Sinusitis—Varenicline—nicotine dependence	0.00422	0.00553	CcSEcCtD
Ritonavir—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.0041	0.0173	CbGpPWpGaD
Ritonavir—Hallucination—Varenicline—nicotine dependence	0.00402	0.00527	CcSEcCtD
Ritonavir—Hypoaesthesia—Varenicline—nicotine dependence	0.00402	0.00527	CcSEcCtD
Ritonavir—Urinary tract disorder—Varenicline—nicotine dependence	0.00399	0.00523	CcSEcCtD
Ritonavir—Oedema peripheral—Varenicline—nicotine dependence	0.00398	0.00521	CcSEcCtD
Ritonavir—Connective tissue disorder—Varenicline—nicotine dependence	0.00397	0.0052	CcSEcCtD
Ritonavir—Urethral disorder—Varenicline—nicotine dependence	0.00396	0.00519	CcSEcCtD
Ritonavir—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00391	0.0165	CbGpPWpGaD
Ritonavir—Visual impairment—Varenicline—nicotine dependence	0.00389	0.0051	CcSEcCtD
Ritonavir—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00386	0.0163	CbGpPWpGaD
Ritonavir—Erythema multiforme—Varenicline—nicotine dependence	0.00382	0.005	CcSEcCtD
Ritonavir—Eye disorder—Varenicline—nicotine dependence	0.00377	0.00495	CcSEcCtD
Ritonavir—Tinnitus—Varenicline—nicotine dependence	0.00376	0.00493	CcSEcCtD
Ritonavir—Cardiac disorder—Varenicline—nicotine dependence	0.00375	0.00491	CcSEcCtD
Ritonavir—Angiopathy—Varenicline—nicotine dependence	0.00366	0.0048	CcSEcCtD
Ritonavir—Immune system disorder—Varenicline—nicotine dependence	0.00365	0.00478	CcSEcCtD
Ritonavir—Mediastinal disorder—Varenicline—nicotine dependence	0.00364	0.00477	CcSEcCtD
Ritonavir—Chills—Varenicline—nicotine dependence	0.00362	0.00475	CcSEcCtD
Ritonavir—Mental disorder—Varenicline—nicotine dependence	0.00354	0.00464	CcSEcCtD
Ritonavir—Malnutrition—Varenicline—nicotine dependence	0.00352	0.00461	CcSEcCtD
Ritonavir—Flatulence—Varenicline—nicotine dependence	0.00346	0.00454	CcSEcCtD
Ritonavir—Dysgeusia—Varenicline—nicotine dependence	0.00344	0.00451	CcSEcCtD
Ritonavir—Back pain—Varenicline—nicotine dependence	0.0034	0.00446	CcSEcCtD
Ritonavir—Muscle spasms—Varenicline—nicotine dependence	0.00338	0.00443	CcSEcCtD
Ritonavir—Vision blurred—Varenicline—nicotine dependence	0.00331	0.00434	CcSEcCtD
Ritonavir—Tremor—Varenicline—nicotine dependence	0.00329	0.00432	CcSEcCtD
Ritonavir—Ill-defined disorder—Varenicline—nicotine dependence	0.00326	0.00427	CcSEcCtD
Ritonavir—Anaemia—Varenicline—nicotine dependence	0.00325	0.00426	CcSEcCtD
Ritonavir—Agitation—Varenicline—nicotine dependence	0.00323	0.00423	CcSEcCtD
Ritonavir—Malaise—Varenicline—nicotine dependence	0.00317	0.00415	CcSEcCtD
Ritonavir—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00317	0.0134	CbGpPWpGaD
Ritonavir—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00316	0.0133	CbGpPWpGaD
Ritonavir—Vertigo—Varenicline—nicotine dependence	0.00316	0.00414	CcSEcCtD
Ritonavir—Syncope—Varenicline—nicotine dependence	0.00315	0.00413	CcSEcCtD
Ritonavir—Palpitations—Varenicline—nicotine dependence	0.00311	0.00407	CcSEcCtD
Ritonavir—Loss of consciousness—Varenicline—nicotine dependence	0.00309	0.00405	CcSEcCtD
Ritonavir—Cough—Varenicline—nicotine dependence	0.00307	0.00402	CcSEcCtD
Ritonavir—Convulsion—Varenicline—nicotine dependence	0.00305	0.00399	CcSEcCtD
Ritonavir—Hypertension—Varenicline—nicotine dependence	0.00303	0.00398	CcSEcCtD
Ritonavir—Arthralgia—Varenicline—nicotine dependence	0.00299	0.00392	CcSEcCtD
Ritonavir—Myalgia—Varenicline—nicotine dependence	0.00299	0.00392	CcSEcCtD
Ritonavir—Chest pain—Varenicline—nicotine dependence	0.00299	0.00392	CcSEcCtD
Ritonavir—Anxiety—Varenicline—nicotine dependence	0.00298	0.00391	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00297	0.0039	CcSEcCtD
Ritonavir—Discomfort—Varenicline—nicotine dependence	0.00296	0.00388	CcSEcCtD
Ritonavir—Dry mouth—Varenicline—nicotine dependence	0.00293	0.00384	CcSEcCtD
Ritonavir—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00289	0.0122	CbGpPWpGaD
Ritonavir—Oedema—Varenicline—nicotine dependence	0.00287	0.00376	CcSEcCtD
Ritonavir—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00285	0.012	CbGpPWpGaD
Ritonavir—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00283	0.0119	CbGpPWpGaD
Ritonavir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00282	0.0119	CbGpPWpGaD
Ritonavir—Shock—Varenicline—nicotine dependence	0.00282	0.0037	CcSEcCtD
Ritonavir—Nervous system disorder—Varenicline—nicotine dependence	0.00281	0.00369	CcSEcCtD
Ritonavir—Thrombocytopenia—Varenicline—nicotine dependence	0.00281	0.00368	CcSEcCtD
Ritonavir—Tachycardia—Varenicline—nicotine dependence	0.0028	0.00367	CcSEcCtD
Ritonavir—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00279	0.0118	CbGpPWpGaD
Ritonavir—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00279	0.0118	CbGpPWpGaD
Ritonavir—Skin disorder—Varenicline—nicotine dependence	0.00279	0.00365	CcSEcCtD
Ritonavir—Hyperhidrosis—Varenicline—nicotine dependence	0.00277	0.00363	CcSEcCtD
Ritonavir—Anorexia—Varenicline—nicotine dependence	0.00273	0.00358	CcSEcCtD
Ritonavir—Hypotension—Varenicline—nicotine dependence	0.00268	0.00351	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00261	0.00343	CcSEcCtD
Ritonavir—Insomnia—Varenicline—nicotine dependence	0.00259	0.0034	CcSEcCtD
Ritonavir—Dyspnoea—Varenicline—nicotine dependence	0.00256	0.00335	CcSEcCtD
Ritonavir—Somnolence—Varenicline—nicotine dependence	0.00255	0.00334	CcSEcCtD
Ritonavir—Dyspepsia—Varenicline—nicotine dependence	0.00253	0.00331	CcSEcCtD
Ritonavir—Decreased appetite—Varenicline—nicotine dependence	0.00249	0.00327	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00248	0.00325	CcSEcCtD
Ritonavir—Fatigue—Varenicline—nicotine dependence	0.00247	0.00324	CcSEcCtD
Ritonavir—Pain—Varenicline—nicotine dependence	0.00245	0.00322	CcSEcCtD
Ritonavir—Constipation—Varenicline—nicotine dependence	0.00245	0.00322	CcSEcCtD
Ritonavir—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00245	0.0103	CbGpPWpGaD
Ritonavir—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00241	0.0102	CbGpPWpGaD
Ritonavir—Feeling abnormal—Varenicline—nicotine dependence	0.00236	0.0031	CcSEcCtD
Ritonavir—Gastrointestinal pain—Varenicline—nicotine dependence	0.00235	0.00307	CcSEcCtD
Ritonavir—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00234	0.00989	CbGpPWpGaD
Ritonavir—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00229	0.00968	CbGpPWpGaD
Ritonavir—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00229	0.00966	CbGpPWpGaD
Ritonavir—Urticaria—Varenicline—nicotine dependence	0.00228	0.00299	CcSEcCtD
Ritonavir—Abdominal pain—Varenicline—nicotine dependence	0.00227	0.00297	CcSEcCtD
Ritonavir—Body temperature increased—Varenicline—nicotine dependence	0.00227	0.00297	CcSEcCtD
Ritonavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00218	0.00921	CbGpPWpGaD
Ritonavir—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00215	0.00909	CbGpPWpGaD
Ritonavir—Hypersensitivity—Varenicline—nicotine dependence	0.00211	0.00277	CcSEcCtD
Ritonavir—Asthenia—Varenicline—nicotine dependence	0.00206	0.0027	CcSEcCtD
Ritonavir—Pruritus—Varenicline—nicotine dependence	0.00203	0.00266	CcSEcCtD
Ritonavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00201	0.00848	CbGpPWpGaD
Ritonavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00199	0.0084	CbGpPWpGaD
Ritonavir—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00198	0.00837	CbGpPWpGaD
Ritonavir—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00198	0.00836	CbGpPWpGaD
Ritonavir—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00196	0.00829	CbGpPWpGaD
Ritonavir—Diarrhoea—Varenicline—nicotine dependence	0.00196	0.00257	CcSEcCtD
Ritonavir—Dizziness—Varenicline—nicotine dependence	0.0019	0.00249	CcSEcCtD
Ritonavir—SLC47A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00187	0.0079	CbGpPWpGaD
Ritonavir—Vomiting—Varenicline—nicotine dependence	0.00182	0.00239	CcSEcCtD
Ritonavir—Rash—Varenicline—nicotine dependence	0.00181	0.00237	CcSEcCtD
Ritonavir—Dermatitis—Varenicline—nicotine dependence	0.00181	0.00237	CcSEcCtD
Ritonavir—Headache—Varenicline—nicotine dependence	0.0018	0.00236	CcSEcCtD
Ritonavir—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00179	0.00753	CbGpPWpGaD
Ritonavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00177	0.00747	CbGpPWpGaD
Ritonavir—Nausea—Varenicline—nicotine dependence	0.0017	0.00223	CcSEcCtD
Ritonavir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0017	0.00718	CbGpPWpGaD
Ritonavir—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00168	0.0071	CbGpPWpGaD
Ritonavir—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00168	0.00709	CbGpPWpGaD
Ritonavir—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00166	0.007	CbGpPWpGaD
Ritonavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00163	0.00687	CbGpPWpGaD
Ritonavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00161	0.00681	CbGpPWpGaD
Ritonavir—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00138	0.00582	CbGpPWpGaD
Ritonavir—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00132	0.00557	CbGpPWpGaD
Ritonavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00131	0.00554	CbGpPWpGaD
Ritonavir—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0013	0.00547	CbGpPWpGaD
Ritonavir—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00129	0.00546	CbGpPWpGaD
Ritonavir—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00129	0.00544	CbGpPWpGaD
Ritonavir—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00124	0.00525	CbGpPWpGaD
Ritonavir—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00123	0.00518	CbGpPWpGaD
Ritonavir—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.00122	0.00514	CbGpPWpGaD
Ritonavir—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00122	0.00513	CbGpPWpGaD
Ritonavir—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0012	0.00507	CbGpPWpGaD
Ritonavir—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0012	0.00506	CbGpPWpGaD
Ritonavir—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00112	0.00472	CbGpPWpGaD
Ritonavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00106	0.00449	CbGpPWpGaD
Ritonavir—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00105	0.00445	CbGpPWpGaD
Ritonavir—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00104	0.00438	CbGpPWpGaD
Ritonavir—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000998	0.00421	CbGpPWpGaD
Ritonavir—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00094	0.00397	CbGpPWpGaD
Ritonavir—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000927	0.00391	CbGpPWpGaD
Ritonavir—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000918	0.00387	CbGpPWpGaD
Ritonavir—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00091	0.00384	CbGpPWpGaD
Ritonavir—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000865	0.00365	CbGpPWpGaD
Ritonavir—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000857	0.00362	CbGpPWpGaD
Ritonavir—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000853	0.0036	CbGpPWpGaD
Ritonavir—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000846	0.00357	CbGpPWpGaD
Ritonavir—SLCO1A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000783	0.0033	CbGpPWpGaD
Ritonavir—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000777	0.00328	CbGpPWpGaD
Ritonavir—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000733	0.00309	CbGpPWpGaD
Ritonavir—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000723	0.00305	CbGpPWpGaD
Ritonavir—ABCC2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000713	0.00301	CbGpPWpGaD
Ritonavir—ABCC1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000704	0.00297	CbGpPWpGaD
Ritonavir—SLCO1B1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000669	0.00282	CbGpPWpGaD
Ritonavir—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00062	0.00262	CbGpPWpGaD
Ritonavir—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0006	0.00253	CbGpPWpGaD
Ritonavir—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000565	0.00239	CbGpPWpGaD
Ritonavir—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000558	0.00235	CbGpPWpGaD
Ritonavir—ABCC1—Disease—AKR1B10—nicotine dependence	0.000424	0.00179	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—CYP2A7—nicotine dependence	0.000367	0.00155	CbGpPWpGaD
Ritonavir—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000335	0.00141	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—CYP2A7—nicotine dependence	0.00033	0.00139	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—CYP2A7—nicotine dependence	0.000314	0.00132	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.00029	0.00123	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000288	0.00121	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000213	0.000898	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—CYP2A7—nicotine dependence	0.000208	0.00088	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000208	0.000878	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.00018	0.00076	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000161	0.000679	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000157	0.000662	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000148	0.000624	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000147	0.000619	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000125	0.000529	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—CYP2A7—nicotine dependence	9.67e-05	0.000408	CbGpPWpGaD
